Side-by-side comparison of AI visibility scores, market position, and capabilities
AI marketing compliance review platform for financial services and healthcare automating FINRA and FDA regulatory checks; $2.8M from YC and Finovate achieving $1.5M revenue competing with Smarsh.
Blee is a New York-based AI compliance review platform for marketing content in financial services and healthcare — automating the review of ads, social media posts, email campaigns, and marketing materials against regulatory requirements (FINRA, SEC, FDA, FTC) and company-specific compliance policies, replacing the manual compliance queue that creates weeks-long bottlenecks between marketing creation and publication. Founded in 2022 and a Y Combinator S22 graduate, Blee raised $2.8 million from Finovate, Cardumen Capital, and Y Combinator, and achieved $1.5 million in revenue in 2024 with a 7-10 person team.
SF YC S23 AI user research platform with 4x revenue growth 2024 serving WeightWatchers, Nestlé, Microsoft; $20.8M total ($17M 8VC Series A 2025) conducting 100x-faster AI-led qualitative interviews competing with Qualtrics for enterprise research automation.
Outset is a San Francisco-based AI user research platform — backed by Y Combinator (S23) with $20.8 million in total funding including a $17 million Series A in 2025 led by 8VC with Future Back Ventures (by Bain), Adverb, Rebel, Genius Ventures, Ritual, and Alt, following a $3.8 million seed in 2023 — providing enterprise research, product, and customer insights teams with an AI-powered interview platform that conducts open-ended qualitative research interviews autonomously, synthesizes responses across hundreds of participants, and delivers structured insights 100x faster than human-led qualitative research methods. Founded in 2023 by Aaron Cannon and Michael Hess, Outset serves enterprise customers including WeightWatchers, Nestlé, and Microsoft, and achieved 4x revenue growth in 2024 with 20% month-over-month revenue growth.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.